⚡Today

Gene-editing treatment poised for first US approval to work inside the body

Nature 12 November 2026 1 min read

⏮ BeforeEarlier CRISPR treatments require removing a participant's cells first.
✅ NowA new therapy alters genes inside the body and is poised for first FDA approval.

In short

  • Earlier CRISPR treatments require removing a participant's cells first.
  • That removal step is complex and costly.
  • The new approach alters genes inside the body and is poised for first FDA approval.

Why it's good news

Earlier CRISPR treatments take cells out of the body, edit them, and return them, which is complex and expensive. A therapy that edits genes inside the body would skip that step. The source says the therapy is poised for approval, not that it has been approved.

Advertisement

From Nature

Nature, Published online: 12 November 2026; doi:10.1038/d41586-026-03705-9 Earlier CRISPR treatments require removal of a participant’s cells, a complex and costly approach.

Read the full story at Nature Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor